| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0016 | 1 |